Trade OXFORD BIOMEDICA PLC ORD 50P - OXB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.190 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023925% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002007% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.96 |
| Open | 3.965 |
| 1-Year Change | 111.02% |
| Day's Range | 3.955 - 4.1 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 3.965 | 0.000 | 0.00% | 3.965 | 4.105 | 3.950 |
| Jan 16, 2025 | 3.960 | 0.039 | 0.99% | 3.921 | 4.050 | 3.901 |
| Jan 15, 2025 | 3.921 | 0.010 | 0.26% | 3.911 | 3.995 | 3.791 |
| Jan 14, 2025 | 3.841 | -0.159 | -3.97% | 4.000 | 4.090 | 3.821 |
| Jan 13, 2025 | 4.020 | 0.000 | 0.00% | 4.020 | 4.095 | 3.975 |
| Jan 10, 2025 | 4.020 | -0.010 | -0.25% | 4.030 | 4.130 | 3.990 |
| Jan 9, 2025 | 4.025 | 0.000 | 0.00% | 4.025 | 4.095 | 3.936 |
| Jan 8, 2025 | 3.990 | -0.080 | -1.97% | 4.070 | 4.150 | 3.975 |
| Jan 7, 2025 | 4.070 | -0.125 | -2.98% | 4.195 | 4.220 | 4.070 |
| Jan 6, 2025 | 4.160 | 0.035 | 0.85% | 4.125 | 4.240 | 4.115 |
| Jan 3, 2025 | 4.140 | -0.055 | -1.31% | 4.195 | 4.225 | 4.095 |
| Jan 2, 2025 | 4.120 | 0.070 | 1.73% | 4.050 | 4.230 | 4.050 |
| Dec 31, 2024 | 4.195 | 0.160 | 3.97% | 4.035 | 4.200 | 4.035 |
| Dec 30, 2024 | 4.140 | 0.020 | 0.49% | 4.120 | 4.230 | 4.085 |
| Dec 27, 2024 | 4.175 | 0.120 | 2.96% | 4.055 | 4.240 | 4.055 |
| Dec 24, 2024 | 4.175 | 0.010 | 0.24% | 4.165 | 4.280 | 4.150 |
| Dec 23, 2024 | 4.245 | 0.100 | 2.41% | 4.145 | 4.255 | 4.065 |
| Dec 20, 2024 | 4.165 | 0.095 | 2.33% | 4.070 | 4.250 | 4.070 |
| Dec 19, 2024 | 4.165 | 0.065 | 1.59% | 4.100 | 4.250 | 4.035 |
| Dec 18, 2024 | 4.165 | 0.015 | 0.36% | 4.150 | 4.250 | 4.150 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Oxford BioMedica plc Company profile
About Oxford BioMedica plc
Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The Company's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The Company has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.
Financial summary
BRIEF: For the six months ended 30 June 2021, Oxford BioMedica plc revenues increased from £34M to £81.3M. Net income totaled £18.1M vs. loss of £6.7M. Revenues reflect Europe segment increase from £19M to £70.3M. Net Income reflects Platform segment income totaling £24.4M vs. loss of £3.1M. Basic Earnings per Share excluding Extraordinary Items increased from -£0.09 to £0.22.
Equity composition
10/2003, Rights Issue, 27 new shs for every 50 shs held @ GBP 0.17 (Fct:1.54). 03/2001, Rights Issue, 1 new share for every 9 shs held @ GBP 0.55 (Fct:1.111111). 03/1998, Rights Issue, 1 new share for every 4 shs held @ GBP 0.10 (Fct:1.076). 05/2014, Priority Issue, 1 new shares for every 5 shares held @ GBp 2 (Factor:1).
| Industry: | Bio Therapeutic Drugs |
Windrush Court
Transport Way
OXFORD
OXFORDSHIRE OX4 6LT
GB
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com